ALB and hepatocellular carcinoma: In addition, a study conducted by Ho et al. [99] showed that a high pre-treatment serum easy ALB–BIL grade independently predicted worse OS in HCC patients treated with curative surgical resection, liver transplantation, local ablation therapy, TACE, systemic chemotherapy, molecular targeted therapy, or supportive care.